Emerging Tools for Stroke Prevention in Atrial Fibrillation

Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Voukalis, Christos, Lip, Gregory Y.H., Shantsila, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776061/
https://www.ncbi.nlm.nih.gov/pubmed/26981569
http://dx.doi.org/10.1016/j.ebiom.2016.01.017
_version_ 1782419082731061248
author Voukalis, Christos
Lip, Gregory Y.H.
Shantsila, Eduard
author_facet Voukalis, Christos
Lip, Gregory Y.H.
Shantsila, Eduard
author_sort Voukalis, Christos
collection PubMed
description Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile.
format Online
Article
Text
id pubmed-4776061
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47760612016-03-15 Emerging Tools for Stroke Prevention in Atrial Fibrillation Voukalis, Christos Lip, Gregory Y.H. Shantsila, Eduard EBioMedicine Review Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke prevention requires the use of the vitamin K antagonists or non-vitamin K oral anticoagulants (NOACs). This article summarises the latest developments in the field of stroke prevention in AF and aims to assist physicians with the choice of oral anticoagulant for patients with non-valvular AF with different risk factor profile. Elsevier 2016-01-15 /pmc/articles/PMC4776061/ /pubmed/26981569 http://dx.doi.org/10.1016/j.ebiom.2016.01.017 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Voukalis, Christos
Lip, Gregory Y.H.
Shantsila, Eduard
Emerging Tools for Stroke Prevention in Atrial Fibrillation
title Emerging Tools for Stroke Prevention in Atrial Fibrillation
title_full Emerging Tools for Stroke Prevention in Atrial Fibrillation
title_fullStr Emerging Tools for Stroke Prevention in Atrial Fibrillation
title_full_unstemmed Emerging Tools for Stroke Prevention in Atrial Fibrillation
title_short Emerging Tools for Stroke Prevention in Atrial Fibrillation
title_sort emerging tools for stroke prevention in atrial fibrillation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776061/
https://www.ncbi.nlm.nih.gov/pubmed/26981569
http://dx.doi.org/10.1016/j.ebiom.2016.01.017
work_keys_str_mv AT voukalischristos emergingtoolsforstrokepreventioninatrialfibrillation
AT lipgregoryyh emergingtoolsforstrokepreventioninatrialfibrillation
AT shantsilaeduard emergingtoolsforstrokepreventioninatrialfibrillation

Ejemplares similares